NADH: Reduced Coenzyme for Energy and Cognitive Support
⚡ 60-Second Summary
NADH (reduced nicotinamide adenine dinucleotide) is the electron-carrying form of NAD+. During cellular respiration, NADH donates its electrons to the mitochondrial electron transport chain, driving ATP production. Unlike NAD+ precursors (NMN, NR), which raise intracellular NAD+ by supplying biosynthetic building blocks, supplemental NADH is intended to directly deliver the reduced coenzyme.
NADH has been most studied for chronic fatigue syndrome (ME/CFS), jet lag, Parkinson's disease, and cognitive function. The most compelling human evidence is for fatigue syndromes, where several controlled trials have shown benefit.
NADH stability is a challenge. NADH is chemically unstable and oxidizes readily. Stabilized, enteric-coated formulations are necessary for meaningful oral bioavailability. Not all NADH products on the market are equivalent in stability or bioavailability.
What is NADH?
The theoretical rationale for NADH supplementation differs from NAD+ precursors: instead of raising intracellular NAD+ through biosynthesis, oral NADH aims to directly supply the reduced coenzyme. The extent to which oral NADH actually delivers intact NADH to mitochondria is debated — significant conversion and oxidation likely occurs in the GI tract and circulation.
NADH research has been driven primarily by Austrian physician George Birkmayer, who patented stabilized NADH formulations (ENADA/Panmol). Most human clinical trials use Birkmayer's formulations, and results may not generalize to generic NADH products.
Evidence-based benefits
Chronic fatigue syndrome (ME/CFS)
Multiple small RCTs using stabilized NADH (5–20 mg/day) show significant fatigue reduction and improved quality of life in ME/CFS patients; effect sizes are clinically meaningful.
Jet lag and shift work fatigue
Small trials show reduced subjective fatigue and improved alertness with NADH taken before/after transmeridian travel.
Parkinson's disease
Birkmayer's early case series and small trials suggested motor improvement with IV NADH; oral supplementation evidence is weaker.
Cognitive function
Small trials show improvements in attention and working memory in healthy adults with stabilized NADH; preliminary.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Stabilized enteric-coated tablets | 5–20 mg/day | Required form | Unstabilized NADH degrades before absorption; only use verified stabilized products |
| NADH capsules (stabilized) | 5–10 mg/day | Convenient | Must verify stability; Birkmayer ENADA is most studied brand |
| Sublingual NADH | Varies | Bypasses some GI degradation | Limited independent evidence for this delivery route |
How much should you take?
- 5–10 mg/day is the most studied dose for fatigue
- Take on an empty stomach 30 minutes before breakfast for best absorption
- Higher doses (20 mg) used in some ME/CFS trials
Stabilized NADH is generally well tolerated. The main concern is product stability — unstabilized NADH products have little value. Most adverse effects are mild and transient.
Safety and side effects
Common side effects
- Nausea at higher doses
- Mild GI discomfort
- Stimulant-like effects (insomnia if taken late in the day)
Serious risks
NADH has minimal known drug interactions. Its energizing effects may interfere with sleep if taken in the afternoon or evening. People with bipolar disorder should exercise caution due to potential mood-activating effects.
Drug and nutrient interactions
- Stimulant medications — additive stimulant-like effects
- Bipolar disorder medications — NADH may have mood-activating properties; monitor
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| People with chronic fatigue syndrome / ME/CFS | One of the few supplements with controlled trial evidence specifically for this condition |
| Frequent travelers experiencing jet lag | Small evidence base but promising; low-risk option |
| People with Parkinson's disease | Early case-series data; discuss with neurologist; stronger evidence for IV than oral route |
| Healthy adults seeking energy enhancement | Evidence is limited; NAD+ precursors (NMN, NR) have a larger and more robust human evidence base for NAD+-related effects |
Frequently asked questions
Is NADH the same as NAD+?
No. NADH is the reduced form (carries electrons) and NAD+ is the oxidized form. They interconvert in cellular metabolism. As supplements, NAD+ precursors (NMN, NR) raise intracellular NAD+ by biosynthesis; NADH is intended to directly deliver the reduced form.
Does NADH actually get absorbed intact?
This is debated. NADH degrades easily, which is why stabilized, enteric-coated formulations are essential. The extent to which oral NADH reaches tissues as intact NADH vs. degradation products is not fully characterized.
Why is NADH studied for chronic fatigue?
ME/CFS is associated with mitochondrial dysfunction and impaired cellular energy production. NADH is central to ATP synthesis, so supplementation is theoretically targeted at the underlying bioenergetic deficit.
How is NADH different from NMN or NR?
NMN and NR are biosynthetic precursors — the body uses them to make more NAD+. NADH is intended to directly supply the active reduced coenzyme. They are different approaches to improving NAD+ metabolism.
Can NADH keep me awake?
Yes — its stimulant-like properties can cause insomnia if taken in the afternoon or evening. Take NADH in the morning on an empty stomach.
Related ingredients
NAD+ Precursors (NMN & NR)
Biosynthetic NAD+ boosters with stronger and more recent evidence base
CoQ10
Mitochondrial energy supplement with overlapping fatigue research
Rhodiola Rosea
Adaptogen with evidence for fatigue reduction
Shilajit
Mineral resin with adaptogenic and mitochondrial energy evidence
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.